GRAViceptive NEGlect Treatment in Acute Stroke Using Targeted Cranial ELECTrotherapy

Who May Qualify: - Supratentorial ischemic stroke diagnosed by neuroimaging and clinical analysis; - Clinically stable (stable vital signs for 24 hours; no chest pain in the last 24 hours; no significant arrhythmia; no evidence of deep vein thrombosis); - Normal or corrected-to-normal vision; - No previous experience with HD-tDCS; - Ability to provide willing to sign a consent form (patient or legal representative); - Ability to comply with the intervention and assessment schedule of the protocol. - Presence of visual verticality misperception. Who Should NOT Join This Trial: - Migraine; - Pregnancy; - Pacemakers; - Seizures; - Claustrophobia; - Transient ischemic attack; - Other neurological disorders; - Psychiatric disorders; - Sensitive scalp or prior brain surgery; - Diagnosis of severe carotid atherosclerotic disease (stenosis ≥ 70%); - Presence of metal implants, cardiac pacemakers, or claustrophobia; - Diagnosis of COVID-19 or other infectious disease that requires isolation; - Uncontrolled medical problems, such as terminal cancer or kidney disease. - Left-handed or mixed-handed individuals as determined using the Edinburgh Handedness Inventory (Appendix 10); - Peripheral vestibular deficits observed using neuro-otological screening tests when the participant's clinical condition allows (head shake test, head thrust test, Dix-Hallpike, and Pagnini-McClure); - Prior musculoskeletal disorders affecting alignment and postural balance (e.g., moderate to severe scoliosis; torticollis); - Cognitive dysfunction outside normal limits on the Mini-Mental State Examination (score below 23); - Global or Wernicke's aphasia; Always talk to your doctor about whether this trial is right for you.